Literature DB >> 8390810

Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

E J Goldstein1, D M Citron.   

Abstract

The in vitro activities of sparfloxacin, temafloxacin, ciprofloxacin, ofloxacin, clarithromycin, erythromycin, tetracycline, cephalothin, penicillin G, and amoxicillin-clavulanic acid against 173 recent clinical bite wound isolates were determined by agar dilution. Sparfloxacin was active against all strains (MIC for 90% of strains tested, < or = 1 micrograms/ml) except for most fusobacteria and one-third of the Prevotella spp. The other fluoroquinolones had similar activities but higher MICs, especially for streptococci. Clarithromycin was more active against many isolates including Pasteurella multocida than erythromycin, with MICs of < or = 2 micrograms/ml (versus 4 micrograms/ml for erythromycin).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390810      PMCID: PMC187919          DOI: 10.1128/AAC.37.5.1150

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  In vitro activity of sparfloxacin.

Authors:  N X Chin; J W Gu; K W Yu; Y X Zhang; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors:  E J Goldstein; D M Citron; G A Richwald
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy.

Authors:  E J Goldstein; D M Citron; A E Vagvolgyi; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Antibiotic susceptibilities of human isolates of Pasteurella multocida.

Authors:  D L Stevens; J W Higbee; T R Oberhofer; E D Everett
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.

Authors:  A L Barry; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

7.  Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Microbiology of human and animal bite wounds in children.

Authors:  I Brook
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129

9.  The development of macrolides: clarithromycin in perspective.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

10.  Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.

Authors:  D J Hardy; D M Hensey; J M Beyer; C Vojtko; E J McDonald; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

View more
  8 in total

1.  Short report: Ceftriaxone for cat and dog bites. Simple outpatient treatment.

Authors:  Ross A Pennie; Thomas A Szakacs; Fiona M Smaill; Marek Smieja; Deborah Yamamura; Barrie McTaggart; Andrew McCallum
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

2.  Postoperative care of the facial laceration.

Authors:  Nicholas Medel; Neeraj Panchal; Edward Ellis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-12

3.  Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; D M Citron; S Hunt Gerardo; M Hudspeth; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; S Hunt Gerardo; M Hudspeth; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; M Hudspeth; S Hunt Gerardo; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

6.  Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.

Authors:  E J Goldstein; D M Citron; C V Merriam; K Tyrrell; Y Warren
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Authors:  E J Goldstein; C A Nesbit; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

8.  Prosthetic joint infection by cat scratch.

Authors:  Jac Ciampolini; John Timperley; Marina Morgan
Journal:  J R Soc Med       Date:  2004-09       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.